Function of CD147 in Atherosclerosis and Atherothrombosis

T cells in atherosclerosis

(2013) K. Tse et al.   INTERNATIONAL IMMUNOLOGY

Oxidized low-density lipoprotein-induced CD147 expression and its inhibition by high-density lipoprotein on platelets in vitro

(2013) Sheng-Hua Yang et al.   THROMBOSIS RESEARCH

The Extracellular Matrix Metalloproteinase Inducer (EMMPRIN, CD147) - a potential novel target in atherothrombosis prevention?

(2013) Nader Joghetaei et al.   THROMBOSIS RESEARCH

A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis

(2012) Smriti M Agrawal et al.   Journal of Neuroinflammation

Low-Salt Diet and Cyclosporine Nephrotoxicity: Changes in Kidney Cell Metabolism

(2012) Jelena Klawitter et al.   JOURNAL OF PROTEOME RESEARCH

Disrupting the EMMPRIN (CD147)–Cyclophilin A Interaction Reduces Infarct Size and Preserves Systolic Function After Myocardial Ischemia and Reperfusion

(2011) Peter Seizer et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

CD147 (Basigin/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells

(2011) T. Solstad et al.   BLOOD

Macrophages in the Pathogenesis of Atherosclerosis

(2011) Kathryn J. Moore et al.   CELL

Intracoronary upregulation of platelet extracellular matrix metalloproteinase inducer (CD147) in coronary disease

(2011) Andy Yong et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

EMMPRIN (CD147/basigin) mediates platelet-monocyte interactionsin vivoand augments monocyte recruitment to the vascular wall

(2011) C. SCHULZ et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Atherosclerosis: current pathogenesis and therapeutic options

(2011) Christian Weber et al.   NATURE MEDICINE

Monocyte CD147 is induced by advanced glycation end products and high glucose concentration: possible role in diabetic complications

(2010) W. Bao et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Pro-inflammatory activities induced by CyPA–EMMPRIN interaction in monocytes

(2010) Wei Yuan et al.   ATHEROSCLEROSIS

Pathological roles of MAPK signaling pathways in human diseases

(2010) Eun Kyung Kim et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Involvement of HAb18G/CD147 in T cell activation and immunological synapse formation

(2010) Jinsong Hu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Expression of CD147 (EMMPRIN) on neutrophils in rheumatoid arthritis enhances chemotaxis, matrix metalloproteinase production and invasiveness of synoviocytes

(2010) Cong-Hua Wang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

CD147 is highly expressed on peripheral blood neutrophils from patients with psoriasis and induces neutrophil chemotaxis

(2010) Hui LU et al.   JOURNAL OF DERMATOLOGY

Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration

(2009) Balachandar Venkatesan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Expression of CD147 on phorbol-12-myris-tate-13-acetate (PMA)-treated U937 cells differentiating into foam cells

(2009) H.H. Yue et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Suppressors of Cytokine Signaling Modulate JAK/STAT-Mediated Cell Responses During Atherosclerosis

(2009) Guadalupe Ortiz-Muñoz et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation

(2009) Peter Seizer et al.   ATHEROSCLEROSIS

CD147 Impacts Angiogenesis and Metastasis Formation

(2009) Heike Voigt et al.   CANCER INVESTIGATION

Upregulation of HAb18G/CD147 in activated human umbilical vein endothelial cells enhances the angiogenesis

(2009) Yanke Chen et al.   CANCER LETTERS

Immune System and Atherosclerotic Disease

(2009) Kazunori Shimada   CIRCULATION JOURNAL

The E-Selectin Ligand Basigin/CD147 Is Responsible for Neutrophil Recruitment in Renal Ischemia/Reperfusion

(2009) N. Kato et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Expression of EMMPRIN (CD147) on circulating platelets in vivo

(2009) G. J. PENNINGS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The Stimulation of CD147 Induces MMP-9 Expression through ERK and NF-κB in Macrophages: Implication for Atherosclerosis

(2009) Ju-Young Kim et al.   Immune Network

Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMA-induced THP-1 cells

(2008) Zhouqing Huang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets

(2008) Anthony J. Muslin   CLINICAL SCIENCE

Targeting the chemotactic function of CD147 reduces collagen-induced arthritis

(2008) Jesse M. Damsker et al.   IMMUNOLOGY

Prevention of Ischemia/Reperfusion-Induced Accumulation of Matrix Metalloproteinases in Rat Lung by Preconditioning With Nitric Oxide

(2008) Thomas Waldow et al.   JOURNAL OF SURGICAL RESEARCH

Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis

(2008) Y. Yang et al.   RHEUMATOLOGY

Extracellular Matrix Metalloproteinase Inducer (CD147) Is a Novel Receptor on Platelets, Activates Platelets, and Augments Nuclear Factor κB–Dependent Inflammation in Monocytes

(2007) Roland Schmidt et al.   CIRCULATION RESEARCH

EMMPRIN mediates β-adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes

(2007) Deborah A. Siwik et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY